INTRODUCTION {#sec1}
============

Virulence-associated type III secretion systems (T3SS) that serve the injection of bacterial effector proteins into eukaryotic host cells are among the most complex membrane-localized molecular machines known. These 6 MDa machines, also called injectisomes, consist of almost 20 different proteins with copy numbers ranging from 1 to more than 100 (Zilkenat *et al.*[@bib168]) (Fig. [1](#fig1){ref-type="fig"}). Their principle mechanism of protein secretion has evolved from the T3SS responsible for self-assembly of bacterial flagella (Abby and Rocha [@bib1]), however, injectisomes are able to secrete a much greater diversity of substrate proteins (Galán [@bib63]). In addition, they have evolved to sense host-cell contact and to inject their substrates through a translocon pore in the host cell membrane (Rosqvist *et al.*[@bib129]; Collazo and Galan [@bib27]; Park *et al.*[@bib120]). T3SS injectisomes are utilized by many different Gram-negative pathogens and symbionts to modulate interaction with host cells, among them human pathogens like Chlamydia, enterophathogenic *Escherichia coli* (EPEC), *Pseudomonas aeruginosa*, *Salmonella*, *Shigella* or *Yersinia*, plant pathogens like *Erwinia*, *Pseudomonas syringae* or *Xanthomonas*, and plant symbionts like *Rhizobium* (Büttner [@bib20]). As different as the lifestyles of T3SS-utilizing bacteria are the diverse cellular functions of the effector repertoire secreted by them. Injected effector proteins serve in prevention of phagocytosis (*Yersinia*), in killing of macrophages (*Salmonella*), in bacterial entry into nonphagocytic cells (*Salmonella*), in interference with immune responses (e.g. *Salmonella*, *Yersinia* and *Xanthomonas*), in mediating tight adhesion (EPEC), or in acquisition of nutrients (*Chlamydia* and *Salmonella*) (Galán [@bib64]). Although secreted effectors fulfill very different functions and are structurally diverse, they are all secreted in an unfolded conformation by a common ATP and proton-motive force (PMF)-driven one-step secretion mechanism involving an N-terminal secretion signal, and often also cognate targeting chaperones.

![Structure and function of the T3SS injectisome. **A.** Bacteria utilize T3SS to inject bacterial effector proteins into eukaryotic host cells. **B.** Structure of the T3SS indicating the different structural units (color-coded) and the individual components. Protein names are given in C. **C.** Nomenclature of T3SS components. The unified nomenclature (Uni) according to Hueck (1998) is shown on the left, the nomenclature of the T3SS encoded by *Salmonella* pathogenicity island 1 (SPI-1) is shown on the right. The nomenclature of the most commonly studied systems in *Yersinia* and pathogenic *Escherichia coli* follow the unified nomenclature with Ysc and Esc, respectively, instead of Sct. Abbreviations: IM, inner membrane; OM, outer membrane.](fny201fig1){#fig1}

Here, we review the recent progress on elucidating assembly, structure and function of T3SS injectisomes that mediate secretion and injection of these effectors. Throughout this review we will refer to the components of the injectisome according to the unified nomenclature introduced previously (Hueck [@bib78]) (Fig. [1](#fig1){ref-type="fig"}). For a comprehensive table of the nomenclature, we refer to a recent review (Deng *et al.*[@bib36]) and to the STEP database.

STRUCTURE OF THE INJECTISOME {#sec2}
============================

Base {#sec2-1}
----

The injectisome is anchored in the bacterial cell envelope by a base composed of the proteins SctC, SctD and SctJ; 12--15 SctC form an outer membrane secretin complex, similar to the secretins found in type II secretion systems (Kowal *et al.*[@bib87]; Worrall *et al.*[@bib160]; Filloux and Voulhoux [@bib58]). T3SS secretins consist of three N-terminal N-domains (N0, N1 and N3) that protrude deeply into the periplasm, a C-domain that forms the outer membrane portal, and an S-domain through which a cognate pilotin binds the secretin and mediates its targeting and assembly (Worrall *et al.*[@bib160]). The N0- and N1-domains form structural motifs that are also found in SctD and SctJ. They were coined ring-building motifs for their ability to mediate ring formation of these base components (Spreter *et al.*[@bib143]). The C-domain forms a unique double-layered β-barrel. Its outer barrel extends towards the outer membrane where it forms a concave membrane association domain. The inner barrel extends into the channel lumen to form a gate separating the periplasmic space from the outside (Worrall *et al.*[@bib160]).

SctC is linked to the inner membrane-localized SctD by its N0-domain (Schraidt *et al.*[@bib132]). SctD contains a single transmembrane segment (TMS), a periplasmic domain composed of two ring-building motifs as well as a small N-terminal cytoplasmic FHA domain (Spreter *et al.*[@bib143]). SctJ contains an N-terminal lipid anchor and often a single C-terminal transmembrane segment. The periplasmic domain of SctJ is composed of two ring-building motifs (Yip *et al.*[@bib164]): 24 SctD and 24 SctJ form two concentric rings with SctD on the outside and SctJ on the inside, hence, SctD is also referred to as outer inner ring protein and SctJ as inner inner ring protein (Schraidt and Marlovits [@bib133]).

Cytoplasmic components {#sec2-2}
----------------------

SctK, SctQ, SctL, SctN and SctO are the cytoplasmic components of the injectisome. Because of their role in recruiting chaperone-substrate complexes according to the hierarchy state of secretion, SctK, SctQ and SctL are also referred to as a sorting platform (Lara-Tejero *et al.*[@bib93]). The cytoplasmic components exist in an injectisome-bound form and as free cytoplasmic complexes (Lara-Tejero *et al.*[@bib93]; Diepold *et al.*[@bib41]; Diepold *et al.*[@bib42]; Zhang *et al.*[@bib167]). The injectisome-bound SctK and SctQ form six pods that bind through a single SctK to the cytoplasmic domains of four SctD each (Hu *et al.*[@bib77]; [@bib76]). Because of an internal start codon, *sctQ* is translated into two polypeptides of different lengths (SctQ~FL~ and SctQ~C~), and the presence of both polypeptides is essential for injectisome assembly and T3SS function (Bzymek, Hamaoka and Ghosh [@bib21]; Diepold *et al.*[@bib41]; McDowell *et al.*[@bib105]; Song *et al.*[@bib139]). Stoichiometry estimates based on fluorescence microscopy (Diepold *et al.*[@bib42]; Zhang *et al.*[@bib167]) and structural analysis of SctQ complexes (Bzymek, Hamaoka and Ghosh [@bib21]; Notti *et al.*[@bib117]; McDowell *et al.*[@bib105]) suggest that 24 SctQ~FL~ and 48 SctQ~C~ are associated with each injectisome. Based on the density observed by cryo-electron tomography (Hu *et al.*[@bib76]) it is unlikely, however, that each pod contains four SctQ~FL~ and eight SctQ~C~, and thus it is improbable that all SctQ are part of these visible structures. A homodimer of SctL connects the six pods to the hexameric ATPase SctN (Notti *et al.*[@bib117]; Imada *et al.*[@bib80]; Diepold *et al.*[@bib42]; Hu *et al.*[@bib76]). A single SctO is located at the center of the SctN hexamer and protrudes towards the cytoplasmic domain of the major export apparatus protein SctV (Ibuki *et al.*[@bib79]; Hu *et al.*[@bib76]).

Export apparatus {#sec2-3}
----------------

The export apparatus of T3SS consists of five hydrophobic proteins that are highly conserved between injectisome and flagellar T3SS: SctR, SctS, SctT, SctU and SctV (Wagner *et al.*[@bib152]). Nine protomers of the major export apparatus protein SctV are located in the central membrane patch of the base (Abrusci *et al.*[@bib2]). The transmembrane domain (TMD) of SctV is predicted to contain four plus four TMS with a sizable conserved loop in between that may form the entrance of the translocation channel in the inner membrane (Barker *et al.*[@bib12]; Erhardt *et al.*[@bib54]). SctV contains a large cytoplasmic C-terminus composed of four subdomains that forms a nonameric ring with a central pore of 50 Å in diameter (Worrall, Vuckovic and Strynadka [@bib161]; Abrusci *et al.*[@bib2]). SctU is a protein with four predicted TMS and a cytoplasmic C-terminal domain that undergoes autocleavage at a conserved NPTH motif (Allaoui *et al.*[@bib5]; Deane *et al.*[@bib31]; Zarivach *et al.*[@bib166]; Lountos *et al.*[@bib100]; Wiesand *et al.*[@bib158]). Unfortunately, cryo-electron tomography of injectisomes or flagella has not so far resulted in assigning a specific location within the complex to SctU, but crosslinking analysis identified protein-protein interactions between the predicted TMDs of SctU and SctR, also placing SctU in the central membrane patch of the injectisome (Dietsche *et al.*[@bib45]). The minor export apparatus proteins SctR, SctS and SctT were predicted to contain four, two and six TMS, respectively; however, the recently solved cryo-electron microscopy structure of an SctRST complex of the flagellar homologs revealed that these proteins hardly make membrane contact in the assembled injectisome but are clamped within the SctJ ring at a periplasmic position above the membrane (Kuhlen *et al.*[@bib91]). They form an unusual helical assembly with five SctR most distal to the membrane, followed by one SctT and four SctS. The predicted transmembrane hairpins form the building blocks of the helix, of which SctR contributes two, SctS one, and SctT three. SctT is a structural fusion of SctR and SctS. It serves to compensate for the helical rise between the first and fifth SctR and stabilizes the assembled structure (Dietsche *et al.*[@bib45]; Kuhlen *et al.*[@bib91]). The assembled SctRST complex forms a translocation pore with an inner diameter of about 15 Å (Radics, Königsmaier and Marlovits [@bib127]; Dietsche *et al.*[@bib45]; Kuhlen *et al.*[@bib91]). In the pre-secretion state, the complex possesses three gates: highly conserved Gln and Met line the mouth of the pore, a loop provided by SctT closes the pore entrance from the inside, and the N-termini of SctR and SctT constrict the exit of the pore (Kuhlen *et al.*[@bib91]). Upon assembly of the helical filament, this most distal end of the SctRST complex makes intimate contacts with the inner rod (Dietsche *et al.*[@bib45]), which might stabilize the pore in an open conformation.

Filament, needle tip and translocon {#sec2-4}
-----------------------------------

The helical needle filament composed of more than 100 copies of SctF (Broz *et al.*[@bib17]) is connected to the distal end of the SctRST complex by about six copies of the inner rod protein SctI (Marlovits *et al.*[@bib103]; Dietsche *et al.*[@bib45]; Zilkenat *et al.*[@bib168]; Kuhlen *et al.*[@bib91]). SctF forms a helical hairpin with a disordered and weakly conserved outward-facing N-terminus and a conserved loop and inward-facing C-terminus (Loquet *et al.*[@bib99]; Demers *et al.*[@bib34]; [@bib33]). The SctRST complex and the needle filament have a very similar helical rise (4.0 and 4.3 Å per subunit, respectively) and number of subunits per turn (5.7 and 5.6, respectively), ensuring a tight anchoring of the filament to the export apparatus and base (Kuhlen *et al.*[@bib91]). However, while the termini of the subunits of the SctRST complex face outwards, the termini of the needle filament protein SctF face inwards, which may explain why the adapter SctI is needed to tightly connect export apparatus and needle filament. The inner diameter of the needle filament is 20 Å, which only allows passage of unfolded substrates (Loquet *et al.*[@bib99]). The highly conserved inner surface of the needle filament is mostly polar.

The needle of most injectisomes ends with a pentameric needle tip complex formed by the hydrophilic translocator protein SctA (Mueller *et al.*[@bib114]; Broz *et al.*[@bib17]; Epler *et al.*[@bib50]). Pathogenic *Escherichia coli* (EPEC and EHEC) possess an additional filament of up to 1 μm length instead (Sekiya *et al.*[@bib134]). Based on their structure, two classes of tip proteins can be distinguished: those similar to IpaD from *Shigella* (Erskine *et al.*[@bib55]; Johnson *et al.*[@bib81]; Chatterjee *et al.*[@bib23]; Lunelli *et al.*[@bib101]; Rathinavelan *et al.*[@bib128]) and those similar to LcrV from *Yersinia* (Derewenda *et al.*[@bib37]). One prominent difference between these two classes of tip proteins is the way they prevent self-aggregation in the bacterial cytoplasm: while IpaD-like proteins possess an N-terminal alpha-helical hairpin that fulfills a self-chaperoning function (Johnson *et al.*[@bib81]), LcrV-like proteins are bound by specific chaperones (e.g. LcrG in Yersinia) (DeBord, Lee and Schneewind [@bib32]; Matson and Nilles [@bib104]). Penetration of the host cell membrane is achieved by formation of a so-called translocon complex, which is composed of multiple copies of two different hydrophobic translocator proteins, SctB and SctE (Montagner, Arquint and Cornelis [@bib113]; Dickenson *et al.*[@bib38]; Park *et al.*[@bib120]). These proteins are predicted to contain 1--2 TMS that insert into the host cell membrane with support from the tip complex (Marenne *et al.*[@bib102]). One copy of SctE may form part of the tip complex in order to fulfill this function (Veenendaal *et al.*[@bib150]; Harmon *et al.*[@bib72]; Cheung *et al.*[@bib26]).

TYPE III SECRETION-INDEPENDENT ASSEMBLY OF THE INJECTISOME {#sec3}
==========================================================

Assembly of the injectisome is a highly coordinated process to ensure the efficient formation of secretion- and membrane translocation-competent machines. The details of the assembly process have been reviewed extensively (Diepold and Wagner [@bib43]), so we will only provide an overview and focus on the most recently gained insights. Two phases of injectisome assembly are distinguished: assembly of the principle secretion-competent machine and type III secretion-dependent assembly of the needle filament, tip and translocon.

Assembly of the principle secretion-competent machine is restricted by two factors: the confinement of the inner and outer membrane-embedded parts in a two-dimensional space and the penetration of the peptidoglycan layer. We previously proposed a bipolar model of assembly stating that (i) dependence of base assembly on nucleation by the export apparatus components ensures secretion competence (Fig. [2](#fig2){ref-type="fig"}A), and (ii) dependence of base assembly on secretin formation ensures outer membrane translocation (Fig. [2](#fig2){ref-type="fig"}B) (Diepold and Wagner [@bib43]).

![Assembly of the T3SS injectisome. Protein names are indicated by their last letter, omitting 'Sct'. The assembly pathways are shown from left to right. **A.** Assembly of the inner membrane export apparatus starts with membrane-integrated SctR. SctR (and also SctS and SctT, not shown) folds into a conformation that permits helical assembly. Then five SctR, followed by one SctT and four SctS, assemble into a helical assembly, winding up from the membrane. Recruitment of one SctU and then nine SctV finish the export apparatus assembly. **B.** Outside-in assembly model assuming independent secretin assembly. The export apparatus (the last step in A.) recruits 24 subunits of the inner inner ring protein SctJ. In an independent step, 15 secretin subunits assemble, supported by pilotins, into a pre-pore. PG penetration of the secretin is facilitated by hole-forming PG lytic enzymes. The secretin forms a pore in the outer membrane and recruits the outer inner ring protein SctD. Closure of the outer inner ring is not permitted until the SctJ-export apparatus assembly has been incorporated. **C.** Inside-out assembly model. The export apparatus (the last step in A.) recruits 24 SctJ and 24 SctD, followed by recruitment of the cytoplasmic components. Type III-dependent secretion of early substrates starts, which locally activates PG lytic enzymes in the periplasm to form a hole for secretin assembly. Just above the inner membrane complex, 15 secretin subunits assemble, supported by pilotins, into a pre-pore. Secretin pore formation and subsequent assembly of the needle filament complete the assembly of the injectisome. Abbreviations: IM, inner membrane; OM, outer membrane; PG, peptidoglycan.](fny201fig2){#fig2}

Assembly of the base is nucleated by prior assembly of the core export apparatus components SctR, SctS and SctT, as shown for the T3SS encoded by *Salmonella* pathogenicity island 1 (SPI-1) (Wagner *et al.*[@bib152]). We showed that SctR assembles independently into multimers that are stabilized by recruitment of SctT (Dietsche *et al.*[@bib45]). SctS-SctT interactions were only detected in the presence of SctR (Dietsche *et al.*[@bib45]), further strengthening the notion that export apparatus assembly begins with SctR and proceeds through recruitment of SctT and SctS. Also, the helical structure of the complex of the flagellar SctRST homologs FliPQR suggests that assembly starts with five SctR and proceeds through subsequent recruitment of one SctT and four SctS, even though it cannot be ruled out at this point that the SctRST complex assembles from SctRS heterodimers followed by association of SctT. SctR assembly may be mediated by formation of intramolecular salt bridges in the predicted TMS that stabilize the step-like conformation of the protein (Kuhlen *et al.*[@bib91]). Likewise, intermolecular salt bridges seem to facilitate assembly of SctS onto the SctRT subcomplex. Strong hydrophobic interactions between the predicted TMS of SctR, SctS and SctT are believed to support stepwise winding of the assembling SctRST complex out of the membrane towards the periplasm (Kuhlen *et al.*[@bib91]); however, the details of this unusual process remain to be elucidated. *In vivo* photocrosslinking data suggest that the switch protein SctU assembles onto the SctRST complex before recruitment of SctV (Dietsche *et al.*[@bib45]). In some T3SS, SctV is completely dispensable for assembly of the base (Wagner *et al.*[@bib152]) while it is necessary in others (Diepold *et al.*[@bib40]). Formation of the SctV ring around the assembled SctRSTU complex may further drive the lifting of the helical SctRST complex from the membrane and support interaction with SctJ and formation of the 24-mer SctJ ring (Fig. [2](#fig2){ref-type="fig"}AB).

Outer membrane targeting and assembly of the secretin has been studied mainly for secretins of type II secretion systems but it is likely that the main conclusions can be inferred. Secretin targeting and assembly requires no other T3SS factors except in most cases a so-called pilotin (Sukhan *et al.*[@bib145]; Burghout *et al.*[@bib18]; Diepold *et al.*[@bib40]). The pilotin is a small lipoprotein that is targeted to the outer membrane by the Lol machinery (Collin *et al.*[@bib28]). It binds the C-terminal S-domain of cognate secretins (Okon *et al.*[@bib119]) and facilitates outer membrane targeting of secretin subunits and assembly of the secretin complex in the outer membrane (Burghout *et al.*[@bib18]; Collin *et al.*[@bib28]; Yin, Yan and Li [@bib163]). Multimerization of secretin subunits leading to pre-pore formation is probably driven by interactions between adjacent N3-domains as well as by interactions of the S-domain with the C-domain of an adjacent subunit (Worrall *et al.*[@bib160]). In particular, this latter interaction may be supported by binding of the pilotin to the S-domain (Yin, Yan and Li [@bib163]). Both mutations localizing to the N3-domain interaction site as well as to the S-domain--C-domain interaction site were shown to compromise multimerization of the secretin (Guilvout *et al.*[@bib67]; [@bib68]; Worrall *et al.*[@bib160]). Outer membrane insertion of the pre-pore is a Bam independent process (Hoang *et al.*[@bib75]) and believed to occur through membrane association of an amphipathic helical loop followed by subsequent insertion of the distal β-barrel lip region of the C-domain (Worrall *et al.*[@bib160]) (Fig. [2](#fig2){ref-type="fig"}BC).

The secretin protrudes about 18 nm into the lumen of the periplasm and penetrates the peptidoglycan layer at the N3-domain (Hu *et al.*[@bib77]) (Fig. [2](#fig2){ref-type="fig"}BC). The assembled secretin complex is about 150 Å in diameter. Since the hole size of peptidoglycan is only about 25 Å (Vollmer, Blanot and de Pedro [@bib151]), peptidoglycan reconstruction is required in order to allow penetration of the assembled secretin complex. Some pathogenicity islands encoding for T3SS also contain genes of peptidoglycan lytic enzymes to locally clear the peptidoglycan (Büttner [@bib20]) (Fig. [2](#fig2){ref-type="fig"}BC). These enzymes often seem to be regulated by type III secreted substrates to limit peptidoglycan degradation to the site of complex assembly (Oh *et al.*[@bib118]; Burkinshaw *et al.*[@bib19]) (Fig. [2](#fig2){ref-type="fig"}C). Such a regulation necessitates ongoing type III secretion before interaction of the inner membrane assembly with the secretin, which is incompatible with a strict outside-in assembly model that starts with the secretin. So, two models for integration of the inner and outer membrane assemblies are currently discussed: (i) independent secretin assembly followed by interaction with the outer inner ring protein SctD and subsequent integration of the SctJ-export apparatus assembly (Diepold *et al.*[@bib40]) (Fig. [2](#fig2){ref-type="fig"}B); and (ii) secretin assembly facilitated by peptidoglycan clearing above the already active inner membrane assembly (Fig. [2](#fig2){ref-type="fig"}C) (Burkinshaw *et al.*[@bib19]). The extensive interaction of SctD with SctJ compared with the limited interaction of SctD with SctC also speak in favor of an assembly pathway where the secretin is recruited to a completely finished inner membrane subcomplex; however, different assembly pathways may occur in different bacterial species.

The cytoplasmic components are recruited to the injectisome by interactions of SctK with the cytoplasmic domain of SctD (Hu *et al.*[@bib76]). Interactions of SctO with the cytoplasmic domain of SctV do not seem to contribute to recruitment of the cytoplasmic components as judged by evidence from cryo-electron tomography and fluorescence microscopy (Diepold *et al.*[@bib40]; [@bib44]; Hu *et al.*[@bib76]; Zhang *et al.*[@bib167]). Recruitment of the cytoplasmic components was shown to depend on SctK, SctQ, SctL and SctN in *Yersinia* while SctN was less critical for injectisome recruitment of SctK, SctQ and SctL in *Salmonella* (Lara-Tejero *et al.*[@bib93]; Diepold *et al.*[@bib42]; Zhang *et al.*[@bib167]). The cytoplasmic components already assemble into complexes before recruitment to the injectisome (Lara-Tejero *et al.*[@bib93]; Diepold *et al.*[@bib42]; Zhang *et al.*[@bib167]), however, there does not seem to be one clearly defined injectisome-free complex of cytoplasmic components but a dynamic and adaptive interaction network where new components can be incorporated at any point (Diepold *et al.*[@bib42]). Thus, while incomplete injectisome-free complexes of cytoplasmic components can be observed, injectisome recruitment requires the presence of all components except SctO, at least in *Yersinia*. In *Salmonella*, recruitment of the pod components SctK, SctQ and SctL to the injectisome may precede the association of SctN and SctO instead (Zhang *et al.*[@bib167]).

SUBSTRATE TARGETING AND SECRETION {#sec4}
=================================

Once assembly of the cytoplasmic components is completed, the machine is secretion competent. An N-terminal T3SS signal and often a chaperone-binding domain (CBD) guide export through the injectisome (Wattiau *et al.*[@bib155]; Sory *et al.*[@bib141]). The T3SS secretion signal comprises the first 10--25 residues of T3SS substrates (Sory *et al.*[@bib141]; Rüssmann *et al.*[@bib130]). Its sequence is highly variable and enriched in polar but depleted in charged and hydrophobic amino acids, which is reflected in a lack of secondary structure (Samudrala, Heffron and McDermott [@bib131]). The role of the secretion signal in the targeting mechanism is still unclear. The 20--50 amino acids-long CBD is located downstream of the signal sequence (Cheng, Anderson and Schneewind [@bib24]; Stebbins and Galán [@bib144]). Cognate T3SS chaperones that are often encoded adjacent to their T3SS substrate bind to the CBD and guide the substrate to the cytoplasmic components (Stebbins and Galán [@bib144]; Lara-Tejero *et al.*[@bib93]).

The role of cognate T3SS chaperones often goes beyond the mere targeting of substrates to the injectisome. Many secreted effectors contain localization signals for targeting inside the host cell, e.g. membrane localization domains for peripheral membrane targeting or transmembrane domains for insertion into host membranes. Inside the bacterial cell, chaperones turned out to serve also in preventing the erroneous targeting of membrane-localized effector proteins to the bacterial inner membrane by binding to membrane localization or even transmembrane domains (Letzelter *et al.*[@bib98]; Nguyen *et al.*[@bib116]; Krampen *et al.*[@bib88]). Furthermore, binding of the *Salmonella* chaperone SicA was found to prevent degradation of both SipB and SipC by cytosolic proteases (Tucker and Galan [@bib149]).

The path substrates take through the secretion system is still unclear. It has been shown that chaperone-substrate complexes interact with sorting platform components (Spaeth, Chen and Valdivia [@bib142]; Lara-Tejero *et al.*[@bib93]), with the ATPase (Akeda and Galán [@bib3]), and with the cytoplasmic domain of the major export apparatus protein SctV (Portaliou *et al.*[@bib123]; Xing *et al.*[@bib162]). In light of the assembled injectisome, it is not clear, however, how chaperone-substrate complexes are handed over from one of these components to the other. In fact, there is no direct evidence that chaperone-substrate complexes bind the injectisome-assembled sorting platform or ATPase, and super-resolution microscopy data indicate a disperse distribution of substrates in the cytoplasm that is independent of injectisome components (Zhang *et al.*[@bib167]). In contrast, it was proposed that chaperone-substrate complexes already bind to the injectisome-free sorting platform as well as to the ATPase (Lara-Tejero *et al.*[@bib93]; Diepold *et al.*[@bib41]) (Fig. [3](#fig3){ref-type="fig"}). The dynamic exchange of these cytoplasmic components may reflect the targeting and handing over of chaperone-substrate complexes from the cytoplasm to the injectisome, even though the kinetics of exchange were regarded as too slow to directly reflect secretion (Diepold *et al.*[@bib41]). For the related flagella T3SS, a model was proposed in which a free SctL~2~N complex (FliH~2~I in flagella) binds chaperones and serves as a dynamic carrier, while a flagellum-associated SctN~6~O (FliI~6~J) complex functions as a static substrate loader towards SctV (FlhA) (Bai *et al.*[@bib10]). Similar to flagellar T3SS, SctL was also shown to regulate the ATPase activity of the *Shigella* SctN in an oligomeric state-dependent manner, thus potentially reflecting the free and injectisome-bound functions of this protein complex (Case and Dickenson [@bib22]).

![The secretion pathway through the T3SS injectisome. Chaperone-substrate complexes are loaded onto free complexes of cytoplasmic components. These complexes are believed to serve as dynamic substrate carriers and deliver chaperone-substrate complexes to the injectisome. Here, chaperone-substrates complexes bind to the cytoplasmic domain of the major export apparatus protein SctV. Supported by the action of the ATPase, substrates are dechaperoned, unfolded and inserted into the secretion channel formed by the export apparatus components and the needle filament. Abbreviation: IM, inner membrane.](fny201fig3){#fig3}

Chaperones are stripped from the substrates prior to secretion and substrates are unfolded to accommodate transport through the narrow secretion channel. The ATPase SctN was reported to independently achieve dechaperoning and unfolding of substrates *in vitro* (Akeda and Galán [@bib3]), however, the reports of folded flagellar chaperone-substrate complexes bound to the downstream of the ATPase-located cytoplasmic domain of the major export apparatus protein SctV suggest that the mechanism is more complex *in vivo* (Bange *et al.*[@bib11]; Xing *et al.*[@bib162]). It was even shown that the function of the ATPase is neither required for principal secretion in flagella nor in injectisomes (Minamino and Namba [@bib110]; Paul *et al.*[@bib121]; Erhardt *et al.*[@bib52]) and that only very infrequent ATP hydrolysis is needed for efficient assembly of flagella (Minamino *et al.*[@bib109]). Thus, dechaperoning and substrate unfolding can be accomplished by SctV alone, but the function of the ATPase seems to enhance the efficiency of this process. Interestingly, the ATPase alone is sufficient to fuel secretion in flagella *in vitro*, even in the absence of the PMF (Terashima *et al.*[@bib147]). It is conceivable that the ATPase and SctV dechaperone and unfold substrates in a concerted action linked by SctO.

Secreted substrates are thought to translocate through the pore of SctV towards the entrance of the secretion channel in the inner membrane, which is most likely formed by the TMDs of the nine SctV (Erhardt *et al.*[@bib54]) (Fig. [3](#fig3){ref-type="fig"}). Access to the entrance may be gated by the cytoplasmic domain of SctU, which was proposed to serve as a docking platform for substrates before entering the secretion channel (Evans *et al.*[@bib56]). Substrate translocation itself is mainly fueled by the PMF across the bacterial inner membrane (Lee *et al.*[@bib95]; Shen and Blocker [@bib136]). Several conserved charged residues reside within the predicted TMD of SctV that seem to be implicated in utilization of the PMF (Hara, Namba and Minamino [@bib71]; Minamino *et al.*[@bib108]; Erhardt *et al.*[@bib54]). After translocation across the membrane, substrates travel through the SctRST complex, the inner rod, the needle filament and the needle tip towards the host cell (Dohlich *et al.*[@bib46]; Radics, Königsmaier and Marlovits [@bib127]).

FILAMENT ASSEMBLY, NEEDLE-LENGTH CONTROL AND SUBSTRATE SPECIFICITY SWITCHING {#sec5}
============================================================================

Secretion through T3SS begins with the export of early substrates. In most T3SS, only three different early substrates are secreted: the inner rod protein SctI, the needle filament protein SctF, and the needle-length control protein SctP (Kimbrough and Miller [@bib85]; Kubori *et al.*[@bib90]). While these early substrates seem to be secreted without the help of cognate chaperones in most T3SS, SctF homologs of *Yersinia* Ysc-like T3SS require chaperoning by a heterodimeric complex of class III chaperones (YscG and YscE in *Yersinia*) (Quinaud *et al.*[@bib126]; Sun *et al.*[@bib146]). More detailed studies on the YscG and YscE homologs of *Pseudomonas* (PscG and PscE) revealed that PscG is the main SctF chaperone while PscE serves as a PscG-stabilizing cochaperone (Ple *et al.*[@bib122]). Interestingly, besides specialized SctF chaperones, secretion of early substrates requires the action of the additional components YscX and YscY in Ysc-like T3SS that do not seem to be present in other systems. YscX and YscY bind to the major export apparatus component YscV (SctV), most likely in a 1:1:1 stoichiometry (Diepold *et al.*[@bib44]; Gurung *et al.*[@bib70]). YscY is regarded as a dedicated chaperone of YscX, which is secreted after substrate specificity switching (Day and Plano [@bib30]; Gurung *et al.*[@bib70]). It is tempting to speculate that YscX and YscY serve in recruiting YscF-YscG-YscE complexes to YscV in a manner analogous to the role of the gatekeeper protein in secretion of translocon-type substrates (see below).

The inner rod assembles at the distal end of the SctRST complex, intimately interacting with the N-termini of SctR and SctT (Dietsche *et al.*[@bib45]; Kuhlen *et al.*[@bib91]). A growing body of evidence suggests that the inner rod does not constitute a rod but merely a thin adapter between the export apparatus and the needle filament, hence we suggest the term needle adapter rather than inner rod (Zilkenat *et al.*[@bib168]). The needle is believed to subsequently assemble onto the needle adapter, although this has not been formally proven. However, it has been shown that the needle grows at its distal end (Poyraz *et al.*[@bib124]), implying that needle subunits travel all the way through the needle conduit to the growing tip, where they insert into and elongate the filament. Needle filament elongation is promoted by a special early substrate in some T3SS (e.g. OrgC of SPI-1) that is structurally similar to flagellar capping proteins (Kato *et al.*[@bib83]). Needle elongation is expected to induce the opening of the secretin gate in the outer membrane (Worrall *et al.*[@bib160]).

Based on studies of the flagellar SctP homolog FliK, it is believed that intermittent secretion of the needle-length control protein SctP measures the length of the growing needle (Erhardt *et al.*[@bib53]). Different hypotheses for how this results in the stopping of further needle elongation have been put forward, but no conclusive answer has emerged yet (Galán *et al.*[@bib62]). Folding of the secreted N-terminus of SctP may result in pulling the remainder of the protein out of the growing needle. At a discrete needle length, SctP~N~ folding may no longer be possible, as the relevant part of SctP does not emerge at the needle tip. The deficiency of SctP~N~ folding would result in a lack of pulling, which then may allow the folded C-terminal domain of SctP to interact with the cytoplasmic domain of SctU (Kinoshita *et al.*[@bib86]). The interaction of SctP~C~ with SctU~C~ is believed to bring needle elongation to a halt and to induce a substrate specificity switch, leading to secretion of intermediate substrates. *In vitro*, the interaction of SctU and SctP has been shown (Botteaux *et al.*[@bib15]; Monjarás Feria *et al.*[@bib111]; Ho *et al.*[@bib74]); however, their *in vivo* interaction remains to be proven. According to this model of needle-length control, the length of SctP, and more specifically, the length of its intrinsically disordered internal ruler domain, dictates the length of the needle, which in fact has been shown in a number of T3SS of flagella and injectisomes (Journet *et al.*[@bib82]; Wagner *et al.*[@bib153]; Erhardt *et al.*[@bib51]; Wee and Hughes [@bib156]).

Due to its role in specificity switching from the secretion of early to intermediate substrates, SctU is also called switch protein. Switching relies on autocleavage of the cytoplasmic domain into two polypeptides (Minamino and Macnab [@bib107]; Lavander *et al.*[@bib94]; Ferris *et al.*[@bib57]). While needle-length control and substrate specificity switching are often seen as one mechanism, they can in fact be separated into two independent processes by preventing autocleavage of SctU (Sorg *et al.*[@bib140]; Shen *et al.*[@bib137]; Monjarás Feria *et al.*[@bib112]). These mutants are able to control needle length but are not capable of switching to the secretion of intermediate substrates. This observation suggests that needle-length control (or rather, stopping of needle elongation) is neither executed by assembly of the needle tip at the distal end of the needle, thereby preventing further needle elongation, nor by the mere switching on of secretion of intermediate substrates, which would concomitantly lead to a reduced secretion of early substrates. Consequently, the stopping of further needle elongation upon needle-length control needs to be executed by a hitherto unidentified mechanism that might involve the active stopping of further secretion of early substrates, or a conformational rearrangement of the needle filament disallowing further assembly at its distal end.

As unclear as the mechanism of the stopping of further needle elongation is the mechanism of substrate specificity switching. The central role of SctU in this process was deduced from mutations within the cytoplasmic domain of this protein that could partly suppress the substrate specificity switching-deficient phenotype of a Δ*sctP* mutant (Hirano *et al.*[@bib73]; Kutsukake, Minamino and Yokoseki [@bib92]; Williams *et al.*[@bib159]; Edqvist *et al.*[@bib49]). Originally, it was proposed that the autocleavage event of SctU might be the switch, however, we could show that SctU autocleavage occurs directly after folding of the cytoplasmic domain of SctU and even before incorporation into the base of the T3SS (Monjarás Feria *et al.*[@bib112]). We could also show that it is not the altered surface properties of the cleaved SctU that are critical for substrate specificity switching but the conformational flexibility gained by cleavage (Monjarás Feria *et al.*[@bib112]). The effect of the SctU Δ*sctP* suppressor mutations on the conformational flexibility of SctU~C~ support this notion (Frost *et al.*[@bib61]) and suggest that suppression acts through an increased probability of autonomous switching caused by a greater conformational flexibility. It has been shown that the prevention of autocleavage of SctU simply disallows secretion of intermediate substrates because of differences in their signal sequence. Grafting of a late effector signal sequence onto a needle tip protein fully restored its secretion and its assembly at the needle tip (Sorg *et al.*[@bib140]).

Substrate specificity switching leads to secretion of needle tip proteins and their subsequent assembly at the distal end of the needle filament (Sorg *et al.*[@bib140]). It also leads to a charging of the sorting platform of the injectisome with hydrophobic translocators and to some premature secretion of these proteins (Lara-Tejero *et al.*[@bib93]). In this state, assembly of the machine is completed. It is ready for host-cell contact, translocon pore formation and subsequent injection of effector proteins.

HOST-CELL SENSING AND INJECTION {#sec6}
===============================

Full secretion through the injectisome is only induced upon host-cell sensing by the needle tip *in vivo* but can be mimicked by chemical signals (e.g. congo red and calcium chelation) *in vitro* (Bahrani, Sansonetti and Parsot [@bib8]; Lee, Mazmanian and Schneewind [@bib96]; Blocker *et al.*[@bib14]). The sensing signal is transmitted to the cytoplasmic side of the injectisome to switch to the secretion of late substrates. A T3SS component critical for induction of late substrate secretion is the so-called gatekeeper protein, SctW. Deletion of the gatekeeper typically results in abrogation of the secretion of translocators and oversecretion of late substrates (Forsberg *et al.*[@bib60]; Kubori and Galán [@bib89]; Botteaux *et al.*[@bib16]). SctW was shown to bind to subdomain 2 of SctV~C~ (Lee *et al.*[@bib95]; Shen and Blocker [@bib136]; Portaliou *et al.*[@bib123]; Gaytán *et al.*[@bib65]). The SctV--SctW interaction participates in secretion regulation by providing a dedicated binding site for translocator-chaperone pairs and by occluding a binding site for late substrates (Portaliou *et al.*[@bib123]). Upon sensing host cells, SctW may be released from SctV to permit late substrate secretion. Free SctW is removed from the injectisome through secretion or degradation (Cheng, Kay and Schneewind [@bib25]; Botteaux *et al.*[@bib16]; Yu *et al.*[@bib165]). It was also reported that the autocleaved C-terminal fragment of SctU is dislocated from the remainder of the protein and subsequently secreted upon host-cell sensing of *Yersinia* (Frost *et al.*[@bib61]); however, the functional implications of this release have not been elucidated.

Two different kinds of trigger for induction of late substrate secretion have been proposed: chemical or mechanical sensing of host cells. The needle tip and translocon components may be involved in both of these mechanisms (Veenendaal *et al.*[@bib150]; Armentrout and Rietsch [@bib6]). In the T3SS encoded on *Salmonella* pathogenicity island 2 (SPI-2), transmission of the signal involves a change of pH through the lumen of the needle down to the cytoplasmic components to dislodge a gatekeeper complex (Yu *et al.*[@bib165]). T3SS of other species respond to changes in the calcium concentration by upregulating secretion (Forsberg *et al.*[@bib59]; Deng *et al.*[@bib35]). Whether calcium is sensed on the outside by the tip and the needle or inside by the export machinery is a matter of debate (Deng *et al.*[@bib35]; Shaulov *et al.*[@bib135]; Gaytán *et al.*[@bib65]). For other T3SS, transmission of the host-sensing signal may be of a mechanical nature by propagating a conformational change of protein subunits from the needle tip through the needle and inner rod towards the export apparatus and the cytoplasmic components. A number of mutants in the needle filament subunit SctF and in the inner rod protein SctI support this hypothesis (Kenjale *et al.*[@bib84]; Torruellas *et al.*[@bib148]; Davis and Mecsas [@bib29]; Lefebre *et al.*[@bib97]).

In some T3SS of enteropathogens, effector protein injection is modulated by interaction of the tip complex with environmental small molecules like deoxycholate, which is present at high concentrations in the small intestine. Binding of deoxycholate induces substantial conformational changes of the tip proteins in *Shigella* (Dickenson *et al.*[@bib39]; Bernard *et al.*[@bib13]), leading to an injection-enhancing effect by supporting the recruitment of hydrophobic translocator proteins to the maturing tip complex in preparation of host membrane contact. Even though the tip proteins of the T3SS of *Shigella* and *Salmonella* SPI-1 are structurally very similar, deoxycholate binding does not have an enhancing effect on secretion in *Salmonella* (Wang *et al.*[@bib154]; Lunelli *et al.*[@bib101]), rather, invasion of *Salmonella* is inhibited in the presence of high concentrations of bile salts (Prouty and Gunn [@bib125]).

Upon host-cell sensing, the hydrophobic translocators are inserted into the host membrane, forming multimeric pores for substrate deployment directly into the host cell cytosol (Montagner, Arquint and Cornelis [@bib113]). Formation of the translocon pores completes the pathway for injection of effector proteins from the bacterial cytoplasm directly into the host cell (Park *et al.*[@bib120]). Whether the secretion path is always continuous, or whether effector proteins can also be deployed from the surface of the bacterium through a translocon that is not directly injectisome-associated (Akopyan *et al.*[@bib4]; Edgren *et al.*[@bib48]), remains to be further elucidated.

CONCLUSIONS AND OUTLOOK {#sec7}
=======================

Impressive progress has been made towards elucidating the assembly, structure and function of bacterial type III secretion systems in recent years, not least because of the cryo-electron microscopy revolution. Unfortunately, however, our understanding of the molecular mechanisms of substrate targeting and secretion, of needle-length control and substrate specificity switching, of host-cell sensing and translocon assembly, is still rudimentary and awaits detailed biochemical investigation. Advances in our understanding of T3SS will foster the exploitation of this intricate system for therapeutic (Bai *et al.*[@bib9]; González-Prieto and Lesser [@bib66]) and biotechnological (Widmaier *et al.*[@bib157]; Singer *et al.*[@bib138]; Guo *et al.*[@bib69]; Azam and Tullman-Ercek [@bib7]) purposes, as well as the development of anti-virulence drugs targeting these machines essential for the pathogenicity of many bacteria (Duncan, Linington and Auerbuch [@bib47]; McShan and De Guzman [@bib106]; Mühlen and Dersch [@bib115]).
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